Skip to content

KAPA KAIROS PHARMA LTD

Follow

COM (common), issuer CIK 1962011

6 managers (6 13F filers) reported a position in KAPA shares at 2024-12-31, 406,598 shares in all. 4 filers opened a position and 1 filer sold out during the quarter.

Managers
6
13F filers
6
New
4
Added
0
Reduced
1
Sold out
1
Shares held by filers
406,598

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q4 2024

Filers in the available 13F reports with a share position at 2024-12-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
UMB Bank, n.a.371,115$564K0.01%new13F-HRTimelineThe filing omitted confidential holdings, a later amendment may add them.
Virtu Financial LLCin group Virtu Financial LLC13,656$21K<0.01%-19,05513F-HRTimelineGroup
CITADEL ADVISORS LLCin group CITADEL ADVISORS LLC10,969$16.7K<0.01%new13F-HRTimelineGroup
UBS Group AGin group UBS Group AG10,845$16.5K<0.01%new13F-HRTimelineGroup
BANK OF AMERICA CORP /DE/in group BANK OF AMERICA CORP /DE/13$20<0.01%new13F-HRTimelineGroup
CONCOURSE FINANCIAL GROUP SECURITIES, I…0$00%013F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios.